Show source-provided references
1. Platelet-rich plasma and platelet-rich fibrin in oral surgery: A narrative review
10.17219/dmp/147298 ↗3. Narayanaswamy, R., Patro, B.P., Jeyaraman, N., Gangadaran, P., Rajendran, R.L., Nallakumarasamy, A., Jeyaraman, M., Ramani, P., and Ahn, B.C. (2023). Evolution and Clinical Advances of Platelet-Rich Fibrin in Musculoskeletal Regeneration. Bioengineering, 10.
10.3390/bioengineering10010058 ↗4. Miron, R.J., Fujioka-Kobayashi, M., Sculean, A., and Zhang, Y. (Periodontol. 2000, 2023). Optimization of platelet-rich fibrin, Periodontol. 2000, early view.
10.1111/prd.12521 ↗5. Mourão, C.F., Lowenstein, A., Mello-Machado, R.C., Ghanaati, S., Pinto, N., Kawase, T., Alves, G.G., and Messora, M.R. (2023). Standardization of Animal Models and Techniques for Platelet-Rich Fibrin Production: A Narrative Review and Guideline. Bioengineering, 10.
10.3390/bioengineering10040482 ↗7. Network meta-analysis of platelet-rich fibrin in periodontal intrabony defects
8. Regenerative Potential of Platelet Rich Fibrin (PRF) in Socket Preservation in Comparison with Conventional Treatment Modalities: A Systematic Review and Meta-Analysis
10.1007/s13770-021-00428-y ↗9. Clinical and Radiographic Evaluation of Autologous Platelet-Rich Fibrin With or Without Demineralized Bone Matrix in the Treatment of Grade II Furcation Defects
10. Injectable Platelet-Rich Fibrin—A Revolution in Periodontal Regeneration
11. Al-Sharabi, N., Gruber, R., Sanz, M., Mohamed-Ahmed, S., Kristoffersen, E.K., Mustafa, K., and Shanbhag, S. (2023). Proteomic Analysis of Mesenchymal Stromal Cells Secretome in Comparison to Leukocyte- and Platelet-Rich Fibrin. Int. J. Mol. Sci., 24.
10.21203/rs.3.rs-2917479/v1 ↗12. Effect of Leukocyte-Platelet Rich Fibrin (L-PRF) on Tissue Regeneration and Proliferation of Human Gingival Fibroblast Cells Cultured Using a Modified Method
10.1007/s13770-021-00360-1 ↗14. Martu, M.A., Maftei, G.A., Luchian, I., Stefanescu, O.M., Scutariu, M.M., and Solomon, S.M. (2021). The Effect of Acknowledged and Novel Anti-Rheumatic Therapies on Periodontal Tissues-A Narrative Review. Pharmaceuticals, 14.
10.3390/ph14121209 ↗15. Evaluation of the regenerative capacity of stem cells combined with bone graft material and collagen matrix using a rabbit calvarial defect model
10.5051/jpis.2204880244 ↗16. Platelet-rich fibrin (PRF) in implant dentistry in combination with new bone regenerative technique in elderly patients
10.1016/j.ijscr.2016.09.022 ↗18. Higgins, J.P.T., and Green, S. (2023, September 17). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4. 2023. [Updated August 2023]. Available online: https://training.cochrane.org/handbook.
19. Evaluation of efficacy of autologous platelet-rich fibrin with demineralized-freeze dried bone allograft in the treatment of periodontal intrabony defects
10.4103/0972-124X.115663 ↗20. Clinical and radiographic evaluation of nanocrystalline hydroxyapatite with or without platelet-rich fibrin membrane in the treatment of periodontal intrabony defects
10.4103/0972-124X.148639 ↗21. Crevicular Fluid Growth Factors Release Profile Following the Use of Platelet-Rich Fibrin and Plasma Rich Growth Factors in Treating Periodontal Intrabony Defects: A Randomized Clinical Trial
10.1902/jop.2016.150314 ↗22. Comparative Evaluation of Bioactive Glass Putty and Platelet Rich Fibrin in the Treatment of Human Periodontal Intrabony Defects: A Randomized Control Trial
24. Platelet-Rich Fibrin for the Treatment of Intrabony Periodontal Defects in Patients with Generalized Aggressive Periodontitis: A Randomized Controlled Clinical Study
25. Clinical and radiographic evaluation and comparison of bioactive bone alloplast morsels when used alone and in combination with platelet-rich fibrin in the treatment of periodontal intrabony defects-A randomized controlled trial
10.1002/JPER.18-0416 ↗26. The Combined Effect of Bioactive Glass and Platelet-Rich Fibrin in Treating Human Periodontal Intrabony Defects—A Clinicoradiographic Study
10.4103/ccd.ccd_507_18 ↗27. Clinical and radiographic evaluation of platelet-rich fibrin as an adjunct to bone grafting demineralized freeze-dried bone allograft in intrabony defects
10.4103/jisp.jisp_99_19 ↗28. Comparative assessment of periodontal regeneration in periodontal intraosseous defects treated with PepGen P-15 unaided or in blend with platelet-rich fibrin: A clinical and high-resolution computed tomography scan-assisted volumetric analysis
10.4103/jisp.jisp_351_19 ↗29. Evaluation of platelet-rich fibrin and tricalcium phosphate bone graft in bone fill of intrabony defects using cone-beam computed tomography: A randomized clinical trial
10.4103/jisp.jisp_621_19 ↗30. Expression of Vascular Endothelial Growth Factor Using Platelet Rich Fibrin (PRF) and Nanohydroxyapatite (nano-HA) in Treatment of Periodontal Intra-Bony Defects—A Randomized Controlled Trial
10.1016/j.sjbs.2020.11.027 ↗31. Clinical and Radiographic Analysis of Novabone Putty with Platelet-Rich Fibrin in the Treatment of Periodontal Intrabony Defects: A Randomized Control Trial
10.4103/ccd.ccd_101_20 ↗32. Clinicoradiographic evaluation of advanced-platelet rich fibrin block (A PRF + i PRF + nanohydroxyapatite) compared to nanohydroxyapatite alone in the management of periodontal intrabony defects
10.4103/jisp.jisp_882_20 ↗33. Clinical and radiographic evaluation of platelet rich fibrin and bone graft material (beta-tricalcium phosphate + hydroxyapatite) in the treatment of intrabony defects of periodontitis patients—A randomized controlled trial
34. Comparative Evaluation of Anorganic Bovine Bone Matrix (ABBM) with or without Platelet Rich Fibrin intreatment of Intrabony Defects:A Randomized Controlled Trial
10.47750/pnr.2022.13.S06.224 ↗35. Injectable platelet-rich fibrin with demineralized freeze-dried bone allograft compared to demineralized freeze-dried bone allograft in intrabony defects of patients with stage-III periodontitis: A randomized controlled clinical trial
10.1007/s00784-023-04954-y ↗37. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans
10.1902/jop.2000.71.7.1110 ↗38. Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: A comparative controlled clinical trial
10.1902/jop.2003.74.12.1725 ↗40. Cheah, C.W., Al-Namnam, N.M., Lau, M.N., Lim, G.S., Raman, R., Fairbairn, P., and Ngeow, W.C. (2021). Synthetic Material for Bone, Periodontal, and Dental Tissue Regeneration: Where Are We Now, and Where Are We Heading Next?. Materials, 14.
10.3390/ma14206123 ↗41. Zhao, R., Yang, R., Cooper, P.R., Khurshid, Z., Shavandi, A., and Ratnayake, J. (2021). Bone Grafts and Substitutes in Dentistry: A Review of Current Trends and Developments. Molecules, 26.
10.3390/molecules26103007 ↗43. Comparing efficacies of autologous platelet concentrate preparations as mono-therapeutic agents in intra-bony defects through systematic review and meta-analysis
10.1016/j.jobcr.2023.08.007 ↗44. Effect of platelet-rich fibrin on periapical healing and resolution of clinical symptoms in patients following periapical surgery: A systematic review and meta-analysis
45. Effect of Intracanal Scaffolds on the Success Outcomes of Regenerative Endodontic Therapy—A Systematic Review and Network Meta-analysis
10.1016/j.joen.2022.11.011 ↗46. Regenerating the Pulp-Dentine Complex Using Autologous Platelet Concentrates: A Critical Appraisal of the Current Histological Evidence
10.1007/s13770-020-00291-3 ↗47. Therapeutic efficacy of platelet-rich fibrin on surgical site wound healing in patients undergoing oral carcinoma resection: A meta-analysis
10.1111/iwj.14386 ↗49. Effect of platelet rich fibrin on stability of dental implants: A systematic review and meta-analysis
50. Distinctive Roles of Wnt Signaling in Chondrogenic Differentiation of BMSCs under Coupling of Pressure and Platelet-Rich Fibrin
10.1007/s13770-022-00456-2 ↗51. A comparative evaluation of the effect of platelet rich fibrin matrix with and without peripheral blood mesenchymal stem cells on dental implant stability: A randomized controlled clinical trial
10.1002/term.3290 ↗52. Effectiveness of the platelet-rich fibrin in the control of pain associated with alveolar osteitis: A scoping review
10.1007/s00784-023-05012-3 ↗54. Comparison of the clinical efficacy of concentrated growth factor and advanced platelet-rich fibrin in the treatment of type I multiple gingival recessions: A controlled randomized clinical trial
58. Effect of calcium carbonate nanoparticles, silver nanoparticles and advanced platelet-rich fibrin for enhancing bone healing in a rabbit model
10.1038/s41598-023-42292-x ↗59. The repair and regeneration mechanism of platelet-rich fibrin-promoting tissue after alveolar bone defect through the notch pathway
10.14715/cmb/2023.69.7.14 ↗60. Efficacy of platelet rich fibrin in the reduction of the pain and swelling after impacted third molar surgery: Randomized multicenter split-mouth clinical trial
10.1186/s13005-015-0094-5 ↗61. Improving the reporting quality of reliability generalization meta-analyses: The REGEMA checklist
10.1002/jrsm.1487 ↗63. Treatment of periodontal intrabony defects using bovine porous bone mineral and guided tissue regeneration with/without platelet-rich fibrin: A randomized controlled clinical trial
10.1002/JPER.20-0860 ↗64. Comparative evaluation of the efficacy of platelet-rich fibrin and calcium phosphosilicate putty alone and in combination in the treatment of intrabony defects: A randomized clinical and radiographic study
10.4103/ccd.ccd_1147_16 ↗66. Injectable platelet-rich fibrin polymerized with hydroxyapatite bone graft for the treatment of three-wall intrabony defects: A randomized control clinical trial
10.4103/jisp.jisp_268_22 ↗67. Platelet rich fibrin combined with decalcified freeze-dried bone allograft for the treatment of human intrabony periodontal defects: A randomized split mouth clinical trail
10.3109/00016357.2015.1035672 ↗